Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

0.8602
Delayed Data
As of Dec 08
 +0.009 / +1.06%
Today’s Change
0.78
Today|||52-Week Range
5.39
-73.03%
Year-to-Date
No recent news for DelMar Pharmaceuticals Inc.

Today’s Trading

Previous close0.85
Today’s open0.86
Day’s range0.85 - 0.89
Volume106,840
Average volume (3 months)999,467
Market cap$18.6M
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+8.64%
Earnings growth (this year)+27.03%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book81.54

Competitors

 Today’s
change
Today’s
% change
HTBXHeat Biologics Inc-0.02-5.73%
EYEGEyeGate Pharmaceutic...0.000.00%
KTOVKitov Pharmaceutical...+0.03+1.66%
CYCCCyclacel Pharmaceuti...+0.17+9.29%
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateFebruary 14, 2018
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$8.1M
Net profit margin--

Profile

Sector
Distribution Services
Industry
Wholesale Distributors
Chief Executive Officer &
Director
Saiid Zarrabian
President, Chief Operating Officer &
Director
Jeffrey A. Bacha
Corporate headquarters
Vancouver, British Columbia

Forecasts